Cargando…

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease

BACKGROUND: High-density lipoproteins (HDL) are structurally and metabolically heterogeneous and subclasses with differential effects on coronary heart disease (CHD) might exist. Apolipoprotein (apo) C-III, a small proinflammatory protein that resides on the surface of lipoproteins, enhances the ath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Majken K., Rimm, Eric B., Furtado, Jeremy D., Sacks, Frank M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487368/ https://www.ncbi.nlm.nih.gov/pubmed/23130121 http://dx.doi.org/10.1161/JAHA.111.000232

Ejemplares similares

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Effect of Selective Androgen Receptor Modulator on Cholesterol Efflux Capacity, Size, and Subspecies of HDL Particles
por: Guo, Wen, et al.
Publicado: (2022)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence
por: Hermans, Michel P, et al.
Publicado: (2011)

Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
por: Koch, Manja, et al.
Publicado: (2017)

Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease
por: Furtado, Jeremy D., et al.
Publicado: (2021)

Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol
por: Wilkins, John T., et al.
Publicado: (2014)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis
por: Ma, Weilie, et al.
Publicado: (2016)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
por: Saleheen, Danish, et al.
Publicado: (2015)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Fluorescent Oxidation Products and Risk of Coronary Heart Disease: A Prospective Study in Women
por: Jensen, Majken K., et al.
Publicado: (2013)

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)
por: Aroner, Sarah A., et al.
Publicado: (2018)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

Apolipoproteins and Alzheimer's pathophysiology
por: Koch, Manja, et al.
Publicado: (2018)

Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure
por: Zhao, Qin, et al.
Publicado: (2017)

Multilocus Heterozygosity and Coronary Heart Disease: Nested Case-Control Studies in Men and Women
por: Mukamal, Kenneth J., et al.
Publicado: (2015)

Association of the T+294C polymorphism in PPAR δ with low HDL cholesterol and coronary heart disease risk in women
por: Aberle, Jens, et al.
Publicado: (2006)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study
por: Yun, Shin Young, et al.
Publicado: (2023)

The distinct metabolism between large and small HDL indicates unique origins of human apolipoprotein A4
por: Andraski, Allison B., et al.
Publicado: (2023)

Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina
por: Caselli, Chiara, et al.
Publicado: (2021)

Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects
por: Vuilleumier, Nicolas, et al.
Publicado: (2019)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness
por: Qu, Geyue, et al.
Publicado: (2021)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Cholesterol Determines and Limits rHDL Formation from Human Plasma Apolipoprotein A-II and Phospholipid Membranes
por: Bassett, G. Randall, et al.
Publicado: (2012)

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
por: Wang, Dianhui, et al.
Publicado: (2018)

Associations of high HDL cholesterol level with all-cause mortality in patients with heart failure complicating coronary heart disease
por: Cai, Anping, et al.
Publicado: (2016)

Use of Systems Biology Approaches to Analysis of Genome-Wide Association Studies of Myocardial Infarction and Blood Cholesterol in the Nurses' Health Study and Health Professionals’ Follow-Up Study
por: Reilly, Dermot, et al.
Publicado: (2013)

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
por: Farnier, Michel, et al.
Publicado: (2014)

Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
por: Brinton, Eliot A., et al.
Publicado: (2016)

High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
por: da Luz, Protasio Lemos, et al.
Publicado: (2008)

Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation
por: Rein, Philipp, et al.
Publicado: (2010)

Raising HDL cholesterol in women
por: Eapen, Danny J, et al.
Publicado: (2010)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_09jli1rcuhts6fo0t02lfjqro9